Prevalence and Antimicrobial Susceptibility Profile of Salmonella and Shigella among Diarrheic Patients Attending Selected Health Facilities in Addis Ababa, Ethiopia

Table 2

Antimicrobial susceptibility profile of Salmonella and Shigella isolates.

Antibiotics pattern	Salmonella (n = 36)			Shigella (n = 24)
	S	I	R	S	I	R
AM	32 (88.8)	3 (8.3)	1 (2.7)	11 (45.8)	1 (4.2)	12 (50)
AMC	35 (97.2)	1 (2.8)	0 (0)	16 (66.6)	3 (12.5)	5 (20.8)
AN	32 (88.88)	3 (8.3)	1 (2.8)	21 (87.5)	3 (12.5)	0 (0)
C	36 (100)	0 (0)	0 (0)	23 (95.8)	0 (0)	1 (4.2)
CIP	25 (69.44)	11 (30.6)	0 (0)	13 (54.16)	10 (41.67)	1 (4.2)
CRO	29 (80.6)	6 (16.7)	1 (2.8)	NT	NT	NT
GM	14 (38.9)	21 (58.3)	1 (2.8)	6 (25)	18 (75)	0 (0)
NA	34 (94.4)	1 (2.8)	1 (2.8)	19 (79.2)	0 (0)	5 (20.8)
TE	34 (94.44)	0 (0)	2 (5.6)	15 (62.5)	1 (4.2)	8 (33.3)
S	8 (22.2)	26 (72.2)	2 (5.6)	3 (12.5)	16 (66.7)	5 (20.8)
SXT	35 (97.2)	0 (0)	1 (2.8)	17 (70.88)	2 (8.3)	5 (20.8)
AZM	NT	NT	NT	22 (91.66)	0 (0)	2 (8.3)

Note. AM: ampicillin, AMC: amoxicillin + clavulanic, AN: amikacin, C: chloramphenicol, CIP: ciprofloxacin, CRO: ceftriaxone, GM: gentamicin, NA: nalidixic acid, TE: tetracycline, S: streptomycin, SXT: sulfamethoxazole + trimethoprim, AZM: azithromycin, and NT: not tested.